|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the CVS 8-K filed Feb 26, 2007. PROXY SUPPLEMENT The following supplemental disclosures required by the Delaware Court of Chancery update the joint proxy statement/prospectus included in the Registration Statement on Form S-4, file No. 333-139470, filed by CVS with the Securities and Exchange Commission (the “SEC”) and declared effective by the SEC on January 19, 2007. The information contained in the attached proxy supplement is incorporated by reference into the above-mentioned joint proxy statement/prospectus. We urge you to read carefully this proxy supplement, together with the joint proxy statement/prospectus and the supplemental disclosure on Form 8-K made by Caremark on February 12, 2007. The information contained in this proxy supplement replaces and supersedes any inconsistent information in the joint proxy statement/prospectus. |
| |||||||
